<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="name">Identifying novel anti-angiogenic targets in human breast cancer</item><item key="sample_count">6</item><item key="tags"><item>breast</item></item><item key="id">4188</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-31138</item><item key="species">human</item><item key="slug">identifying-novel-anti-angiogenic-targets-in-human</item><item key="factor_count">1</item></item><item><item key="name">Identifying the molecular signature of the t(12;14) subgroup of uterine leiomyomata using a paired analysis</item><item key="sample_count">27</item><item key="tags"><item>myometrium</item></item><item key="id">3412</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-18096</item><item key="species">human</item><item key="slug">identifying-the-molecular-signature-of-the-t1214-s</item><item key="factor_count">2</item></item><item><item key="name">Identify the cancer stem cells expression characteristics in ovarian and breast cancer</item><item key="sample_count">6</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>ovarian cancer</item></item><item key="id">4619</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-43657</item><item key="species">human</item><item key="slug">identify-the-cancer-stem-cells-expression-characte</item><item key="factor_count">1</item></item><item><item key="name">IFN alpha-induced gene expression in human NK cells</item><item key="sample_count">4</item><item key="tags"><item>disease</item><item>hepatitis</item><item>hepatitis c</item><item>liver</item><item>liver disease</item><item>protein</item><item>serum</item><item>virus infection</item></item><item key="id">3252</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-15743</item><item key="species">human</item><item key="slug">ifn-alpha-induced-gene-expression-in-human-nk-cell</item><item key="factor_count">1</item></item><item><item key="name">IFNb-1a in-vivo treatment induces the expression and signaling of IFNAR1 and inhibits Th17 responses in PBMCs derived from CIS patients</item><item key="sample_count">12</item><item key="tags"><item>cerebrospinal fluid</item><item>cytokine</item><item>disease</item><item>genome</item><item>line</item><item>multiple sclerosis</item><item>rrms</item><item>serum</item></item><item key="id">2033</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-53716</item><item key="species">human</item><item key="slug">ifnb-1a-in-vivo-treatment-induces-the-expression-a</item><item key="factor_count">1</item></item><item><item key="name">IL-17 and TNF synergistically induce growth-associated cytokines in melanocytes while suppressing melanogenesis</item><item key="sample_count">12</item><item key="tags"><item>line</item><item>melanocyte</item><item>serum</item></item><item key="id">2397</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-40413</item><item key="species">human</item><item key="slug">il-17-and-tnf-synergistically-induce-growth-associ</item><item key="factor_count">2</item></item><item><item key="name">IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model</item><item key="sample_count">12</item><item key="tags"><item>cell</item><item>cytokine</item><item>disease</item><item>epidermis</item><item>kcs</item><item>psoriasis</item><item>skin</item><item>skin disease</item></item><item key="id">2116</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-52361</item><item key="species">human</item><item key="slug">il-17-induces-an-expanded-range-of-downstream-gene</item><item key="factor_count">2</item></item><item><item key="name">IL-4 mediated gene expression profiles in vascular endothelial cells</item><item key="sample_count">13</item><item key="tags"><item>atherosclerosis</item><item>cell</item><item>cell adhesion molecule</item><item>chromatin</item><item>deep</item><item>disease</item><item>endothelial cell</item><item>endothelium</item><item>genome</item><item>interleukin</item><item>monocyte</item><item>vascular disease</item></item><item key="id">4006</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-28117</item><item key="species">human</item><item key="slug">il-4-mediated-gene-expression-profiles-in-vascular</item><item key="factor_count">3</item></item><item><item key="name">Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell cycle progression</item><item key="sample_count">27</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>chronic myeloid leukemia</item><item>class</item><item>genome</item><item>hematopoietic system</item><item>leukemia</item><item>myeloid leukemia</item></item><item key="id">2166</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-33075</item><item key="species">human</item><item key="slug">imatinib-therapy-of-chronic-myeloid-leukemia-resto</item><item key="factor_count">2</item></item><item><item key="name">Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.</item><item key="sample_count">44</item><item key="tags"><item>cd3d</item><item>cell</item><item>melanoma</item><item>metastatic melanoma</item></item><item key="id">3503</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-19234</item><item key="species">human</item><item key="slug">immune-profile-and-mitotic-index-of-metastatic-mel</item><item key="factor_count">0</item></item></data></biogps>
